Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
4.750
-0.200 (-4.04%)
Apr 23, 2026, 10:43 AM EDT - Market open
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $6.23 million as of April 23, 2026. Its market cap has decreased by -26.46% in one year.
Market Cap
6.23M
Enterprise Value
-3.80M
1-Year Change
-26.46%
Ranking
Category
Stock Price
$4.75
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $6.23M, an increase of 25.31%. That is a compound annual growth rate of 1.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 6.23M | -10.96% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 6.84M |
| Addex Therapeutics | 6.82M |
| Can-Fite BioPharma | 6.64M |
| Akari Therapeutics, | 6.55M |
| Bio Green Med Solution | 6.51M |
| Alaunos Therapeutics | 6.49M |
| XTL Biopharmaceuticals | 6.34M |
| Aptevo Therapeutics | 6.06M |